Rewiring Saccharomyces cerevisiae metabolism for optimised Taxol® precursors production
Saccharomyces cerevisiae has been conveniently used to produce Taxol® anticancer drug early precursors. However, the harmful impact of oxidative stress by the first cytochrome P450-reductase enzymes (CYP725A4-POR) of Taxol® pathway has hampered sufficient progress in yeast. Here, we evolved an oxida...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Metabolic Engineering Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214030123000123 |